Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $39,674 - $65,311
-392 Reduced 12.13%
2,839 $337,000
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $8,707 - $11,774
102 Added 3.26%
3,231 $344,000
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $278 - $417
4 Added 0.13%
3,129 $311,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $129,767 - $170,417
1,346 Added 75.66%
3,125 $322,000
Q2 2023

Aug 10, 2023

SELL
$118.5 - $160.53 $461,202 - $624,782
-3,892 Reduced 68.63%
1,779 $216,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $400,875 - $582,194
-2,955 Reduced 34.26%
5,671 $870,000
Q4 2022

Feb 08, 2023

SELL
$118.38 - $210.04 $198,878 - $352,867
-1,680 Reduced 16.3%
8,626 $1.55 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $141,093 - $232,045
-1,195 Reduced 10.39%
10,306 $1.29 Million
Q2 2022

Aug 04, 2022

BUY
$117.13 - $176.59 $70,043 - $105,600
598 Added 5.48%
11,501 $1.64 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $194,874 - $362,212
1,541 Added 16.46%
10,903 $1.89 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $2.07 Million - $3.38 Million
9,176 Added 4933.33%
9,362 $2.33 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $1.64 Million - $3.59 Million
-7,400 Reduced 97.55%
186 $186,000
Q2 2021

Aug 11, 2021

SELL
$129.91 - $234.98 $29,099 - $52,635
-224 Reduced 2.87%
7,586 $1.78 Million
Q1 2021

May 07, 2021

BUY
$109.18 - $185.98 $42,580 - $72,532
390 Added 5.26%
7,810 $1.02 Million
Q4 2020

Feb 09, 2021

BUY
$65.74 - $169.86 $4,273 - $11,040
65 Added 0.88%
7,420 $775,000
Q3 2020

Nov 02, 2020

SELL
$54.34 - $94.85 $14,345 - $25,040
-264 Reduced 3.47%
7,355 $520,000
Q2 2020

Aug 10, 2020

SELL
$29.67 - $80.0 $104,586 - $282,000
-3,525 Reduced 31.63%
7,619 $489,000
Q1 2020

May 05, 2020

BUY
$17.78 - $31.58 $198,140 - $351,927
11,144 New
11,144 $333,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gerber Kawasaki Wealth & Investment Management Portfolio

Follow Gerber Kawasaki Wealth & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.